Live Breaking News & Updates on Vice dean global health

First-of-its-kind clinical trial network established in Asia to treat and prevent drug-resistant infections

Wellcome Trust has provided a grant of S$2.5 million to the National University of Singapore to establish the Asian Clinical Research Network to conduct antimicrobial clinical research to develop the most effective ways to treat and prevent life-threatening drug-resistant infections.

Singapore , Australia , United-states , National-university-of-singapore , Singapore-general , Hsu-li-yang , Emily-henderson , Singapore-clinical-research-institute , Nanyang-technological-university , Lee-kong-chian-school-of-medicine , Yong-loo-lin-school-of-medicine , Swee-hock-school-of-public-health

COVID-19 restrictions ahead of Chinese New Year: Rules, risks and responsibilities


COVID-19 restrictions ahead of Chinese New Year: Rules, risks and responsibilities
Heart of the Matter
COVID-19 restrictions ahead of Chinese New Year: Rules, risks and responsibilities
Two weeks before Chinese New Year, what’s behind Singapore’s new restrictions? What is the outlook for the country’s COVID-19 fight amid a raging .
28 Jan 2021 05:25PM
(Updated:
28 Jan 2021 09:50PM)
Two weeks before Chinese New Year, what’s behind Singapore’s new restrictions? What is the outlook for the country’s COVID-19 fight amid a raging pandemic, new mutated variants and rising imported cases? And are there conditions under which the rules can be peeled back as mass testing and nation-wide vaccinations get underway? Lin Suling speaks to Professor Hsu Li Yang, Vice Dean (Global Health) at the NUS Saw Swee Hock School of Public Health, and Professor of Health Services and Systems Research David B Matchar from the Duke-NUS Medical School.

China , Singapore , Chinese , Lin-suling , Hsu-li-yang , Professor-of-health-services , Systems-research-davidb-matchar , Swee-hock-school-of-public-health , Vice-dean-global-health , Chinese-new-year , Professor-hsu-li-yang , Vice-dean